Cite

    Yamazaki, N. et al. (n.d.). High expression of post-treatment Ki-67 status is a risk factor for locoregional recurrence following breast-conserving surgery after neoadjuvant chemotherapy. European journal of surgical oncology. 41 (5), pp. 617-624. [Online].